[Investigation of Enterococcus faecalis antimicrobial resistance].
We performed an antibiotic resistance study on Enterococcus faecalis isolated from intrahospitalary and extrahospitalary samples between january 2004 and january 2008. Three different samples were studied; urine, blood and wound swabs, considering a strain per patient. We included in the study a global amount of 3,641 Enterococcus faecalis isolations from clinical samples received at Hospital Universitario Reina Sofía microbiology service in Córdoba (Spain). We employed semiautomatic system WIDER I (Soria Melguizo) for identification and sensibility testing. We considered sensibility and resistance criteria recommended by MENSURA group. We found a sensitivity rate of 98.04% to betalactamics.The highest resistance rates were obtained with aminoglycosides, between 33.82% and 48.01%. Linezolid and Vancomycin sensitivity was 100%. It seems that vancomycin resistance is not a worrying issue today, but it should be controlled.
Casal
M M
MM
Servicio de Microbiología, Hospital Universitario Reina Sofía, Córdoba (España). mi1carom@uco.es
Cause
M
M
Solís
F
F
Rodríz
F
F
Casal
M
M
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D017714:Community-Acquired Infections / Q000382:microbiology; D003428:Cross Infection / Q000382:microbiology; D024881:Drug Resistance, Bacterial; D013293:Enterococcus faecalis / Q000187:drug effects*; D016908:Gram-Positive Bacterial Infections / Q000453:epidemiology / Q000382:microbiology*; D006801:Humans; D008826:Microbial Sensitivity Tests; D013030:Spain / Q000453:epidemiology
D000900:Anti-Bacterial Agents